Trial Profile
Phase II Evaluation of Mitoguazone Dihydrochloride in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma Associated With Acquired Immunodeficiency Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2013
Price :
$35
*
At a glance
- Drugs Mitoguazone (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 26 Aug 2013 New trial record